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Abstract 
 Secondary lymphedema (SLE) is a serious problem for many of the 2.6 million 
breast cancer survivors in the United States. It is estimated that 28 – 38% of breast cancer 
survivors develop lymphedema. The five-year incidence ranges from 43% to 94% 
(Armer, 2010). The purpose of this study was to evaluate the effectiveness of an 
education program on healthcare personnel’s knowledge of the risk of and preventive 
measures for upper limb lymphedema in breast cancer patients. A sample of healthcare 
personnel (N = 32) included both trained healthcare personnel and ancillary staff who are 
employed in a single oncology center based at two hospitals. Fifteen healthcare personnel 
who attended an educational program on lymphedema detection and prevention and 
seventeen healthcare personnel who did not attend were randomly selected to participate 
in the study. Although there was little variation in the scores between the educated versus 
the uneducated group, the educated group did better. Among the groups, the highest score 
was found in the educated group (97%). The group that did not receive the education 
received a lower score (92%). 
 Levene’s test for equality of variances was found to be violated for the present 
analysis,  F(1,30) = 2.903, p = .099.  Therefore, in order to test the efficacy of the 
lymphedema education, an independent samples t-test not assuming equality of variances 
was conducted and found to be not statistically significant, t (22.637) = 1.798, p = 0.085.   
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Chapter I Introduction 
 Lymphedema is regarded as one of the most dreaded complications following 
breast cancer. Although lymphedema is considered one of the most distressing and 
debilitating complications after breast cancer treatment, its incidence and symptoms are 
not well understood. Early detection and intervention hold the greatest promise of 
reducing and managing this widespread condition in patients who have undergone breast 
cancer treatment (Gergich et al., 2008). Edema is defined as a palpable swelling produced 
by expansion of the interstitial fluid volume. Lymphedema, which is due to an 
abnormality in the lymphatic system is caused by interruption of the axillary lymphatic 
system by surgery and/or radiation therapy in women with breast cancer, resulting in the 
development of arm edema (Mohler, 2012). The lymphatic system can be compromised 
when one or more lymph vessels or nodes (small organ distributed throughout the body 
that transport and filter or trap foreign particles and waste) are surgically removed or stop 
working properly due to disease. Breast cancer comprises 10.4% of all cancer incidences 
among women. Although mortality rates from breast cancer are decreasing (Harris, 
Campbell, & McNeely, 2004), the morbidity associated with the standard treatment of 
lymphedema continues to be significant with decreased shoulder mobility and strength, 
lymphedema, and impaired activities of daily living (Lawrance & Stammers, 2008). Any 
type of procedure that affects the lymphatic system may put you at risk for 
lymphedema—a risk that persists for life. 
 Since there is no cure for lymphedema, precautions and prevention should be 
emphasized. Informing patients by raising awareness might reduce the incidence of 
lymphedema. It has been suggested that prevention programs might reduce the incidence 
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of lymphedema. If lymphedema is left untreated it can become disabling by decreasing 
mobility and increasing dysfunction. 
 The key word in lymphedema management is early. “Education and early 
intervention are huge pieces to lymphedema management” (James, 2012) . Obesity, 
severe fatigue, susceptibility to infection, and heavy trauma to the lymphatic systems 
(such as multiple surgeries and radiation) can increase risk. Healthcare providers, 
informed of the importance of aftercare following breast surgery, have the ability to have 
an impact on reducing the potential physical and psychological complications. Educated 
healthcare providers can empower and encourage patients to be active participants in 
their care following breast surgery. They play an important role in educating women 
about the risks of lymphedema associated with breast cancer as well as identifying 
patients at increased risk. Early identification and prevention are paramount. Teaching 
patients about their risk of lymphedema and how to prevent complications, referring to 
specialists in lymphedema management, reinforcing self-care measures, and offering 
emotional support to patients who experience lymphedema helps minimize the effect of 
lymphedema on quality of life (Singer, 2009).  
Background  
According to Mei R. Fu (2011), the majority of doctors and nurses don’t know 
how to educate patients undergoing breast surgery.  Studies document that the majority of 
patients do not receive basic information about the risk of lymphedema. Healthcare 
providers need to have specialized training that includes risk-reduction education, the 
physiology of lymphedema and preventive measures. “Nurses are on the frontline and 
may hold the key in proactively preventing lymphedema in many patients by educating 
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them about triggers and symptoms, continual and specific lymphedema assessments 
during each visit and pursuing research in this area” (McDowell, 2008).  Unless a nurse 
or healthcare provider specializes in oncology nursing, lymphedema may not be an 
occurrence that they assess and treat frequently. Determination of baseline knowledge of 
lymphedema is essential before beginning education. Following baseline assessment, 
education including definition of lymphedema, cause, assessment, treatment, and 
prevention is necessary (McDowell, 2008).   
Purpose of the Study 
The purpose of this study is to evaluate the effectiveness of an education program 
on healthcare personnel’s knowledge of the risk of and preventive measures for 
lymphedema in breast cancer patients. This knowledge has the potential to improve the 
ability of healthcare personnel to deliver effective patient education, provide quality care 
and improve health outcomes for those at risk for lymphedema.  
Lymphedema is an adverse effect that can be a result of cancer treatment related 
surgical and radiation procedures that damage or disrupt lymphatic structures. It can 
occur immediately or many years after treatment. Healthcare personnel play a pivotal role 
in caring for patients throughout cancer treatment and are sentinels for the early 
assessment of lymphedema risk, prompt identification of lymphedema symptoms, and 
implementation of evidence-based, individualized treatment plans in collaboration with 
lymphedema therapists (Armer, Poage, Poundall, Shellabarger, & Singer, 2008). 
Significance 
 Lymphedema is a common complication following breast cancer surgery and is 
believed to be largely undiagnosed in clinical practice. It is caused by interruption of the 
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lymph drainage in the armpit (axilla) that results in discomfort and swelling of the arm. 
The risk of developing lymphedema depends on the extent of surgery, how many lymph 
nodes were removed, and whether radiation therapy to the axilla was used. Infection 
caused by insect bites or even scratches could precipitate this complication. The highest 
risk for shoulder dysfunction or lymphedema is typically the first four years post surgery. 
Another, not so common problem is shoulder and/or arm dysfunction (Lawrance & 
Stammers, 2008).  
As reported at American Society of Clinical Oncology’s (2009) Breast Cancer 
Symposium, “More cases of lymphedema are seen between six and nine months after 
treatment, but even after 60 months we still see new cases, so there are late-occurring 
cases”. Depending on the criteria used to define lymphedema, the five-year incidence 
ranged from 43% to 94% (Armer, 2010). Awareness and preventive effort are vitally 
important because once symptoms arise it may be too late for prevention. It is critical that 
women are educated, aware, and instructed in prevention strategies and precautionary 
behaviors for avoiding lymphedema. Information about lymphedema should begin when 
they are making decisions about their breast cancer treatment.  
This study makes a significant contribution to nursing knowledge by describing 
and documenting the effect of an education program on healthcare personnel’s 
knowledge of the risk and prevention of lymphedema for women who have had breast 
cancer treatment.  There is a need to educate providers about the situation of women at 
risk for lymphedema, the prevention strategies, treatment modalities, and support groups 
to refer patients appropriately for education and support.  
Findings from this study may be used to improve educational programs for 
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healthcare personnel caring for this patient population. Even though ancillary staff may 
not give direct care to patients, they are more likely to see patients for visits that do not 
require the direct care of the nurse. 
Research Question 
Will healthcare personnel attending an educational program on lymphedema 
demonstrate higher knowledge of lymphedema detection and prevention than those 
healthcare personnel not attending an educational program? 
Theoretical Framework 
Pender’s Revised Health Promotion Model (HPM) guided the framework of this 
study. The HPM was developed as a holistic predictive model of health-promoting 
behavior for use in clinical practice and research (Peterson & Bredow, 2009). Major 
concepts of the HPM include individual characteristics and experiences, behavior specific 
cognitions and affect, and behavioral outcomes.  
 The HPM identifies ten sub-concepts to the three major concepts (see table 1 
below). According to Pender, Individual Characteristics and Experiences include Prior 
related behaviors and Personal biological, psychological, and sociocultural factors. 
Behavior-specific Cognitions and Affect includes: Perceived benefits and barriers to 
action, Perceived Self-efficacy, Activity-related affect, and Interpersonal and Situational 
influences. Behavioral Outcomes includes: Commitment to a plan of action and Health-
promoting behaviors (Peterson & Bredow, 2009).  
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Table 1  
Pender’s Health Promotion Model (HPM) 
 
Individual Characteristics 
& Experiences: 
• Prior	  related	  behaviors	  
• Personal	  biological,	  psychological,	  &	  sociocultural	  factors	  
Behavior-Specific 
Cognition & Affect: 
• Perceived	  benefits	  &	  barriers	  to	  action	  
• Perceived	  self-­‐efficacy	  
• Activity-­‐related	  affect	  
• Interpersonal	  &	  situational	  influences	  
Behavior Outcomes: 
• Commitment	  to	  a	  plan	  of	  action	  
• Health	  promoting	  behaviors	  
 
 This study’s aim, to determine the effect of education on Healthcare Personnel’s 
knowledge of Lymphedema detection and prevention, utilizes three of Pender’s sub-
concepts: Personal factors; Interpersonal influences, and Health-promoting behaviors. In 
this study, Pender’s sub-concept “Personal factors” will be represented by the 
participant’s demographic information as measured by the Demographic Data Sheet.  
Pender’s sub-concept “Interpersonal influences” will be represented by the Lymphedema 
Educational Program.  Pender’s sub-concept “Health-promoting behaviors” will be 
represented by the participant’s knowledge of Lymphedema detection and prevention as 
represented by the scores on the Lymphedema Knowledge Test. 
 Lymphedema may have an adverse influence on quality of life but more 
importantly its relationship with overall survival may extend beyond quality of life to 
quantity of life, emphasizing the importance of identifying evidence-based prevention 
and treatment strategies (National Lymphedema Network, 2009). 
 Healthcare providers should advocate for referral as needed to other specially 
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trained physiotherapists. Patients with cancer should routinely receive education about 
their relative risk for developing lymphedema. Providing education “could help prevent 
and reduce secondary lymphedema in patients after breast cancer surgery involving 
dissection of axillary lymph nodes, at least for one year after surgery” (Torres, 2010). 
Patients should also be told about risk reduction guidelines such as those contained in the 
National Lymphedema Network (2009).  
 Healthcare professionals need continuing education about definition, assessment, 
intervention, and prevention of lymphedema (Armer, Radina, Porock, & Culbertson, 
2003). With this accomplished, patients will benefit with patient education and high 
quality care.   
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Chapter II Literature Review 
 Lymphedema is regarded as one of the most dreaded complications following 
breast cancer. The following chapter reports the state of the literature regarding 
Lymphedema. The studies were located in CINAHL, PUBMED and MEDLINE using the 
key terms: 1) axillary lymph node dissection--surgery to check for cancer in lymph nodes 
in the armpit, 2) lymph node--round mass of lymph fluid and white blood cells that filter 
bacteria and waste from the body, 3) lymphedema--condition in which excess fluid, 
called lymph, collects in tissues and causes swelling, 4) sentinel lymph node biopsy--
surgery to check for cancer in the first lymph nodes in the armpit where cancer is like to 
travel, 5) cellulitis--infection and swelling that causes skin to be warm, red and tender; 
may also produce fever, chills, swollen lymph nodes or blisters (Living Beyond Breast 
Cancer, 2010).  
Documentation of the problem of lymphedema is readily found in cancer 
survivorship topics. However, reports in medical literature vary widely on estimates of 
lymphedema incidence (Oncology Nurses Society, 2009). Challenges to assessing 
incidence and prevalence stem from difficulty in attaining accurate measurement, 
diagnosis, duration of follow-up and limitation to a particular hospital or clinic. Current 
criteria for staging and grading of lymphedema vary in the literature. Quantification of 
lymphedema is problematic for two reasons. A standard criterion for diagnosing 
lymphedema does not exist and limb measurement methods may vary so a “gold 
standard” for objective measurement does not exist (Armer, 2005; Torres, 2010). 
Data regarding the incidence and prevalence of lymphedema occurring patients are sparse 
and inconclusive (Oncology Nurses Society, 2009). Studies do not provide consistent, 
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clear definitions of lymphedema. Lymphedema can occur not only during cancer 
treatments but also for several years afterward (Armer, 2010). 
 Torres (2010) conducted a study to determine the effectiveness of education on 
early physiotherapy in reducing the risk of lymphedema. This was a quantitative, 
randomized, single blinded, clinical trial of 120 women who had breast surgery with 
axillary dissection between May 2005 and June 2007. In addition to education, a 
physiotherapist treated the early physiotherapy group and also an educational strategy 
was provided. The control group received the education strategy only. The incidence of 
clinically significant secondary lymphedema  (>2cm increase in arm circumference 
measured at two adjacent points compared with the non-affected arm) was evaluated. 
One hundred sixteen (116) women completed the one-year follow-up. Eighteen women 
(16%) developed secondary lymphedema (16%): 14 women in the control group 14 
(25%) and four (7%) women in the intervention group. The difference between the 
groups was statistically significant (p=0.01). A survival analysis showed a significant 
difference, with secondary lymphedema being diagnosed four times earlier in the control 
group than in the intervention group. Early physiotherapy could be an effective 
intervention in the prevention of lymphedema. Weaknesses of this study included the 
limited duration of follow-up and the setting being one hospital. Also, the ambiguous 
definition of lymphedema may have resulted in significant measurement errors. It was 
clear that outcomes of the study might be used for calculations in a larger effect study. 
  In one study assessing incidence of lymphedema following the surgical 
procedure of Axillary Lymph Node Dissection (ALND) 73% of women reported 
restricted shoulder mobility, tightness, edema, pain, and numbness of the arm, and 
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limitations in daily life (Beurskens, Van Uden, Strobbe, Oostendorp, & Wobbes, 2007). 
Physiotherapy has been clinically observed to improve treatment of these patients. The 
goal of Lawrance and Stammer’s (2008) study was to demonstrate that physiotherapy has 
been clinically observed to improve quality of life for patients following breast cancer. 
Presently, there is no standard referral for physiotherapy unless there is edema or 
restricted shoulder function. The researchers utilized a computer-generated random list to 
ensure accuracy of outcomes. Assessments were made at baseline and after three and six 
months. The treatment group received standardized physiotherapy treatment of advice 
and exercises for the arm and shoulder for three months. The control group received a 
leaflet containing advice and exercises. The outcome variable of pain in the shoulder/arm 
was measured by a Visual Analogue Scale and digital inclinometer that was a measure of 
shoulder mobility. The study was conducted over a two-year period from 2003 to 2005. 
Patient characteristics of intervention group and control group indicated no significant 
differences in groups prior to the intervention. Findings indicated physiotherapy, 
beginning two weeks after surgery, improved shoulder function (Lawrance & Stammers, 
2008).  
  Beurskens et al. (2007) investigated the efficacy of physiotherapy treatment of 
shoulder function, pain and quality of life in patients who have undergone breast cancer 
surgery. Thirty patients were included in a randomized quantitative control study. The 
treatment group received standardized physiotherapy treatment of advice and exercises; 
the control group received a leaflet containing advice and exercises. Primary outcome 
variables were amount of pain in the shoulder/arm recorded on the Visual Analogue 
Scale, and shoulder mobility measured on a digital inclinometer under standardized 
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conditions. The researcher was blinded to treatment allocation. All thirty patients 
completed the trial. After three and six months the treatment group showed significant 
improvement in shoulder mobility and had significantly less pain than in the control 
group. Results of the study indicate that quality of life improved significantly, however, 
handgrip and strength and arm volume (edema) did not alter significantly. Beurskens et 
al. (2007) study demonstrated that physiotherapy, which began two weeks after surgery, 
improved shoulder function and quality of life. Limitations of the study included the 
small sample size and short follow-up time of six months. The researchers recommended 
a long-term follow up to provide further information about the lasting improvement and 
occurrence of lymphedema following ALND. The study recommended that larger studies 
with at least a one-year follow-up with relevant outcome measures are needed (Beurskens 
et al., 2007).   
Shoulder morbidity resulting from surgery and effects from radiotherapy (RT) 
results in limited shoulder range of motion (ROM). Axillary dissection can contribute to 
limited shoulder ROM called “axillary web syndrome” (AWS). This may be referred to 
as “cording” Visible and palpable cords may develop within the first six to eight weeks 
after surgery and begin in the axilla and into the forearm. The risk of developing 
lymphedema due to subcutaneous fibrosis and changes in vessel and lymphatic capillary 
walls (thereby affecting circulation) may be three and a half times higher in cases of 
axillary and supraclavicular RT (Harris et al., 2004).  The objective of a quantitative 
study by Nesvold, Dahl, Lokkevik, Mengshoel, and Fossa (2008) was to compare the 
prevalence of late effects in the arm and shoulder in patients with breast cancer stage II 
who had radical modified mastectomy (RM) or breast-conserving therapy (BCT) 
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followed by radiotherapy (RT). Women consecutively treated for stage II breast cancer 
between 1998-2002 at the Norwegian Radium Hospital (NRH) were invited to take part 
in a follow-up study in 2005. The survey consisted of mailed questionnaires in an 
outpatient clinical examination. All patients delivered written informed consent before 
inclusion. Shoulder range of motion ROM was evaluated by goniometry. The women 
were asked to perform active motion to reach the greatest range possible, and the angles 
were recorded in degrees. Findings indicated no significant differences between the 
groups concerning demographic, treatment and medical characteristics. Statistically 
significant difference in ROM between the groups studied was observed. Lymphedema 
was observed in 43 patients (20%) belonging to the RM group compared to 6 (8%) in the 
BCT group. There was no statistically significant difference (p=0.43) in functional 
capacity between the groups. Nine patients had severe lymphedema, all of them 
belonging to the RM group. Six patients in the BCT group had lymphedema in the 
affected breast. Among those with arm lymphedema, 80% reported that the edema had 
developed during the first year after surgery and 17% during the second year. Nesvold et 
al., (2008) reported that compared to the RM group, significantly fewer patients treated 
with BCT suffered from arm/shoulder problems including lymphedema. The results from 
this study support the proposal to provide physical therapy during RT, consisting of 
shoulder exercises. Physical therapy favors the maintenance of shoulder ROM in relating 
to flexion and abduction and minimizes the occurrence of scar tissue formation in women 
with breast cancer, during the first six months of follow-up. Limitations of the study 
included the interval for follow up may have been too short to detect the late effects of 
radiation, such as lymphedema and subcutaneous fibrosis and the physical therapists were 
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not blinded which could result in bias. The researchers recommended longer follow-up 
period to assess whether the promising results from physical therapy (Nesvold et al., 
2008).  
Meta-analysis  
 Bicego et al. (2006) addressed that many women experience secondary 
complications of breast cancer not only from the disease and its treatments but also 
decreased quality of life (QOL), weight gain, sleep disturbances, poor body image, 
fatigue, increased risk for osteoporosis, cardiovascular disease, premature menopause, 
and lymphedema. The purpose of this qualitative study was to review and critique recent 
studies investigating the effects of aerobic exercise and upper extremity resistance 
training for women with or at risk for lymphedema. The questions addressed are: (1) does 
aerobic or resistance exercise lead to lymphedema in women who are at risk for the 
condition? And (2) does aerobic or resistance exercise reduce or exacerbate pre-existing 
lymphedema. The article reviews the prevalence, etiology, pathology, and diagnosis of 
exercise from leading oncology experts. The researchers categorized the level of each 
research study from level II to V, according to Sackett levels. Of the eight studies 
reviewed, the researchers found five were level V, the least rigorous type of experimental 
design. Three studies were categorized as level II, which were small, randomized 
controlled trials, one of which explored lymphedema as an adverse effect rather than an 
outcome. Prior to this study, the idea that aerobic exercise and upper extremity exercise 
should be contraindicated was widely accepted. The studies revealed that exercise neither 
initiated nor exacerbated lymphedema, although more cases of new lymphedema were 
reported in one study (Bicego et al., 2006). Lymphedema related questions such as this 
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require the evaluation of a physical therapist and healthcare personnel are important 
entities in making recommendation for referral. 
 A systematic review by Harris, Campbell, and McNeely (2004) of late morbidity 
after treatment of breast cancer (one year or more after surgery) was done. The review 
included six articles that were methodologically rigorous enough to satisfy rigorous 
inclusion criteria. The review assessed studies evaluating muscle and grip strength. One 
prospective study reported a prevalence of limited range of motion in 20% in patients 
who had sentinel node biopsy and 72% in patients who had axillary dissection. Physical 
activity levels were evaluated in approximately 3,000 women in the Nurses’ Health Study 
who had been diagnosed with stage 1, 2, or 3 breast cancer between 1984 and 1998 and 
were followed until death or June 2002. The primary measured outcome was breast 
cancer mortality risk according to the level of physical activity. 
 The researchers found that studies are currently underway to compare different 
types of exercise following breast cancer treatment. California researchers are studying 
whether weight-bearing resistance exercise can reduce bone loss in women undergoing 
chemotherapy for invasive breast cancer. Other studies are continuing to examine the 
effects of exercise on immune response in breast cancer survivors. Lower incidences of 
lymphedema were found in women who exercised regularly, received lymphedema 
education before treatment, and performed preventive self-care activities. Physical 
therapy guidelines for management of women with breast cancer surgery are minimal 
(Harris, Campbell, & McNeely, 2004).  
All breast cancer patients, with suspected lymph node invasion, need axillary 
node dissection. A study by Devoogdt et al. (2009) investigated the short-and long-term 
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effects of treatment for breast cancer and axillary node dissection on shoulder mobility, 
development of lymphedema, pain and activities of daily living (ADL). Patients who had 
a modified radical mastectomy (33%) or a breast-conserving procedure (67%) were 
included in the study. Shoulder mobility, lymphedema, pain and ADL were evaluated at 
three months and three years after surgery. At long term, 31% of the patients experienced 
impaired shoulder mobility, 18% developed lymphedema, 79% had pain and 51% 
mentioned impaired daily activities. Between three months and three years after surgery, 
impaired shoulder mobility decreased from 57% to 31%. Lymphedema increased from 
4% to 18%. Patients experienced an equal amount of pain but fewer problems with ADL. 
At three years, no significant differences between mastectomy and breast-conserving 
procedure were found. The researchers reported limitations of the study including the 
high rate of patients lost in follow-up and the application of ‘normative values’ to 
interpret shoulder mobility and to compare the involved arm with the uninvolved arm to 
define lymphedema. The researcher recommended further research that included 
measurement of the patients’ arms prior to surgery. The study found at long term, a 
significant number of breast cancer survivors who still had shoulder mobility, developed 
lymphedema, had pain and experienced difficulties during daily activities. Shoulder 
mobility, pain and daily activities had positive improvements but the incidence of 
lymphedema increased.  
 Park, Lee, and Chung (2008) researched women (n=450) with breast cancer who 
had mastectomies. Participants were recruited from outpatient breast cancer clinics in two 
university hospitals in Seoul, Korea from 2004 to 2005 for this quantitative study. 
Lymphedema was defined by circumferential measurement. Risk factors associated with 
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lymphedema were examined. A descriptive design was used and data was collected using 
a questionnaire. 
 The study reported that of the 450 cases of breast cancer, 24.9% had developed 
lymphedema. The higher the staging, the greater extent of breast surgery, including 
axillary lymph node dissection and also body mass increased the risk of lymphedema. 
Women, who exercised regularly, received pretreatment education and performed 
preventive self-care activities had a decreased risk of lymphedema. Since a retrospective 
study was conducted, the results do not include assessment of trends. Park et al. (2008) 
stated other factors that might contribute to lymphedema must be considered. The 
researchers recommend that patients be educated in the symptoms and risk of 
lymphedema. Nurses should inform patients with breast cancer about their risk for 
lymphedema, provide guidelines, and emphasize self-care activities to reduce the risk for 
lymphedema.  
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Chapter III Methodology 
 The purpose of this study is was to determine the effect of an educational program 
on healthcare personnel’s knowledge of lymphedema detection and prevention. 
Lymphedema is regarded as one of the most dreaded complications following breast 
cancer. Its relationship to overall survival may extend beyond quality of life to quantity 
of life. Early detection and intervention hold the greatest promise of reducing and 
successfully managing this widespread, chronic condition. Nursing practice guidelines 
for lymphedema education, assessment, monitoring and management are lacking. 
Providing education on lymphedema “could help prevent and reduce secondary 
lymphedema in patients after breast cancer surgery involving dissection of axillary lymph 
nodes, at least for one year after surgery” (Torres, 2010). Early detection and intervention 
hold the greatest promise of reducing and managing this widespread condition in patients 
who have undergone breast cancer treatment (Gergich et al., 2008).  
 Lymphedema can occur not only during cancer treatment but also for several 
years afterward (Armer, Radina, Porock, & Culbertson, 2003). Survivorship is one of the 
areas Oncology Nurses Society (ONS) began to focus on in 2009. Data regarding the 
incidence and prevalence of lymphedema occurring in patients are sparse and 
inconclusive (Oncology Nurses Society, 2009).  
Sample Population 
 Participation was based on a convenience sample and included both trained 
healthcare personnel and ancillary staff who are employed in a single oncology center 
based at two hospitals.  Fifteen healthcare personnel who attended an educational 
program on lymphedema detection and prevention and seventeen healthcare personnel 
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who did not attend the program participated in the study. 
 Setting 
 The setting for the study to determine the effect of an educational program on 
healthcare personnel’s knowledge of lymphedema detection and prevention includes one 
large healthcare organization in Western North Carolina. The healthcare organization 
includes two acute care hospitals with patient populations consisting of women 
undergoing breast surgery. The average daily census for both of the healthcare facilities is 
100. Hospital A employs approximately 1,000 healthcare personnel and Hospital B 
employs approximately 400 healthcare personnel.  Patients are seen at both hospitals, this 
study was conducted with staff from both hospitals.     
Research design 
 A quasi-experimental design utilizing a convenience sample was used for this 
study to determine the effect of an educational program on healthcare personnel’s 
knowledge of lymphedema detection and prevention. 
Protection of Human Subjects 
 Approval of the University Institutional Review Board (IRB) was obtained prior 
to data collection. Approval of the Healthcare organization was obtained from Director of 
Specialty Services and the Director of Human Resources. Verbal and written explanation 
of the study purpose was given to the participants prior to data collection. Written 
informed consent, ensuring the subject’s right to confidentiality and anonymity, the right 
to ask questions of the investigator, and the right to withdraw from the study was given to 
each participant.  Return of the completed surveys indicated the participant’s consent to 
participate. No identification was indicated on the surveys (see appendix C).  
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Data Collection 
 Healthcare personnel working with patients at risk for lymphedema (n =15) whom 
had previously attended an education presentation on lymphedema prevention and 
detection completed the demographic form and the Lymphedema Knowledge test. 
Healthcare personnel (n =17) who did not attend the education presentation completed 
the demographic form and the Lymphedema Knowledge test.   
Data Analysis 
 Data was stored and analyzed on the principal investigator’s personal computer 
with access to the research files will be password protected. Aggregate data was analyzed 
using the Statistical Package for the Social Sciences, version 19. Statistical analysis 
included descriptive statistics of frequency and measures of central tendencies. The effect 
of the educational program was determined using an independent samples t test. 
Educational Program  
 An educational program on Lymphedema detection and prevention was 
developed by the researcher (see Table 2 below). The Lymphedema educational program 
is outlined in Appendix A and was based on the following facts: 
• Lymphedema is a condition in which excessive fluid and protein accumulate in 
the extravascular and interstitial space (Rockson, 2001). This accumulation of 
fluid and protein occurs when the lymphatic system either cannot accept or 
transport lymph (the colorless fluid that bathes the cells of	  the body, carrying 
away by-products of metabolism and helping to fight infection) into the 
circulatory system (Browse, Burnand, & Mortimer, 2003). 
• Any patient who has treatment for breast cancer, including prophylactic 
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mastectomy (lumpectomy, modified radical mastectomy in combination with 
lymph node removal and/or radiation to the underarm area, breast or chest wall). 
Seven percent of patients with sentinel node biopsy developed significant clinical 
lymphedema in one study. For axillary node dissection the incidence was 49% 
after a 20-year follow-up (McLaughlin, 2008). 
• ALL breast cancer patients, immediately after undergoing surgery that includes 
axillary lymph node dissection and/or radiation, are at risk, for the rest of their 
lives, of developing lymphedema (National Lymphedema Network, 2011). 
• Lymphedema can occur immediately postoperatively, during radiation, within a 
few months, a few years or even decades or more after cancer treatment 
(McLaughlin, 2008).  
Table 2  
Prevention Interventions and Precautions* 
 
Prevention Interventions Strategies and Precautions 
Avoidance of trauma and injury to the arm Use of protective gloves for household  
work and gardening; avoid venipuncture, 
blood pressure measurement, and injections 
in the affected arm; and do not get bitten by 
an insect or scratched by an animal 
Prevention of infection Preventing infection with timely first aid; 
immediately identifying and treating any 
signs of infection; avoiding heat and sun 
exposure; practice meticulous skin and nail 
care; avoid paper cuts 
Avoidance of Arm Constriction Avoiding constrictive clothing and jewelry 
on the affected extremity; wear a padded 
bra strap to avoid pressure; do not carry a 
shoulder bag 
Use and Exercise of the Limb Use the affected limb in moderation; not 
carrying heavy objects; avoiding repetitive 
motion 
*National Lymphedema Network (2009). Lymphedema Risk Reduction Practices. 
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Chapter IV Results 
Demographic Description of Sample  
Thirty-two healthcare personnel participated in the study to determine the effect 
of an educational program on healthcare personnel’s knowledge of lymphedema 
detection and prevention.  Of the sample, 29 (91%) were female, and three (9%) were 
males. Ten (31%) of the healthcare personnel participating in the study were employed in 
Radiation Oncology. The remainder was employed in Medical Oncology, or as ancillary 
staff.   Nine (28%) of the respondents were Registered Nurses. Sixty-two percent had at 
least one degree in the whole sample (N=32), and seven (22%) held Bachelors Degrees. 
Only one healthcare provider held a doctorate degree and four (13%) reported holding 
“Other, or No Degree”. The ages of the participants were between 23 and 70 years (M = 
46.9, SD = 11.68). The study participants had been employed as healthcare providers 
between one and thirty-six years (M = 14.33 SD = 10.95). The number of certificates 
held ranged from 0 to 3 (M = 0.87, SD  = .88). There were five Registered Nurses (RNs) 
in each group. The RNs that received the lymphedema education did slightly better than 
the RNs that received no education (100% vs. 96%, respectively). See Table 3 and 4 for 
the Demographic data for the entire sample (n = 32).  
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Table 3 
Percent Distributions for Demographic data for Sample (n=32) 
 
Lymphedema 
Education(n=15) 
No Lymphedema 
Education (n=17)  
Gender 
   Male 
   Female 
Healthcare Area of Employment 
   Registered Nurse 
   Registration 
   Registration Oncology Staff 
   Certified Medical Assistant 
   Other 
Highest Degree Held 
   Associate 
   Bachelors 
   Masters 
   Doctorate 
   No degree 
 
7% (1) 
93% (14) 
 
33% (5) 
33% (5) 
7% (1) 
13% (2) 
13% (2) 
 
53% (8) 
27% (4) 
0 
0 
20% (3) 
 
12% (2) 
88% (15) 
 
24% (4) 
0 
53% (9) 
12% (2) 
12% (2) 
 
71% (12) 
7% (3) 
0 
6% (1) 
6% (1) 
 
 
Table 4 
Measures of Central Tendencies for Demographic Data for Sample (n=31*) 
Variable Mean SD Deviation Range 
Age 
Years of Experience 
Number of Certifications  
46.97 
14.35 
0.87 
11.68 
10.95 
0.88 
23-70 
1-38 
            0-3 
 
* Demographic data was missing for one participant. 
Demographic Description of Groups 
  Of the 32 study participants who completed a lymphedema quiz, 15 (47%) 
attended a lymphedema educational seminar before taking the quiz, and 17 (53%) did 
not.  Of the 15 who completed the seminar, 14 (93%) were female; of the 17 who did not 
complete the seminar, 15 (88%) were female.  Of the 15 who attended the seminar, five 
(33%) were registered nurses; and of those who did not attend the seminar four (24%) 
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were registered nurses. Ten healthcare personnel from the radiation oncology department 
participated in the study, but only one attended the educational seminar. There was an 
equal number of certified medical assistants and staff who self-identified as ‘other’ in 
each of the two sample groups.  The average age for both groups was similar M = 46.86 
years for those who received education, and M = 47.06 years for those who did not.  The 
groups were also similar for years of experience and number of certifications. Years of 
experience were also very similar, M = 13.73 for the group receiving education, and M = 
14.94 for the group that did not receive education.  The number of certifications was also 
very similar, M = 0.86 for the group receiving the education, compared to M = 0.88 for 
the group that did not (see Tables 4 and 5). 
Table 5 
Measures of Central Tendencies for Groups 
Variable Education 
(n=15) 
 
  M           SD         Range 
No Education 
(n=17) 
 
        M           SD         Range 
Age 
Years of Experience 
Number Certifications  
 46.86      12.14      23-61 
 13.73      11.55       2-36 
   0.86        0.77        0-2 
       47.06     11.68       28-70 
       14.94     10.7           1-38 
         0.88      0.99           0-3 
  
 Regardless of participation in the lymphedema prevention and detection program, 
all participants of both groups identified the correct answer for questions one, and five 
through eight.  In question 2, participants were asked to identify the best way to reduce 
and manage lymphedema. All of the 15 participants who attended the education seminar 
selected the correct response, however, one of the participants who did not attend the 
seminar answered incorrectly. One of the main objectives of this education seminar was 
to teach health care providers how to prevent lymphedema through early detection. The 
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education regarding the actual management of lymphedema was not covered in detail, as 
a physiotherapist does the management. Question 3 had a total of twelve incorrect 
answers counting both groups. This could be due to the inclusion in the educational 
seminar PowerPoint that “any patient who has treatment for breast cancer” is at risk for 
lymphedema. For Question 4 there was one incorrect response given by someone who did 
not attend the educational seminar. It is a common misconception that edema only occurs 
immediately after treatment. Lymphedema can occur months to years after treatment for 
breast cancer. As noted previously, both groups answered questions 5 through 8 
correctly. Question 9 asks about when a patient is at risk for lymphedema; the educated 
group answered all questions correctly but two people in the group that received no 
lymphedema education answered incorrectly. One of the most important facts concerning 
lymphedema is Question 10. There were six incorrect responses to number 10 in the 
group that received no lymphedema education. It is a common misconception that 
lymphedema can be cured. Lymphedema can certainly be treated and over time, 
lymphedema can often improve– but that once the lymphatics are interrupted the most 
important thing is aggressive support and awareness of how to manage the problem as 
best one can along with some physical therapy techniques that might improve the 
alternate drainage patterns in some lymphedema situations and may improve the 
regeneration of lymphatics in some situations, particularly over time. Interruption of the 
lymphatic vessels is a physical problem and lymphedema is a sign – as opposed to the 
symptom – of the lymphatic interruption. Of course, others may consider "cure" to mean 
simply improving or relieving symptoms. One would not really cure the physical 
manifestations of an underlying structural or anatomical disruption or abnormalities. 
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Table 6 
Percentages of Correct Responses for Lymphedema Questions for Groups 
Question Lymphedema 
Education 
(n=15) 
No Lymphedema 
Education 
(n=17) 
1 - What is lymphedema? 
 
2 - Best way to reduce and 
manage lymphedema? 
 
3 - Who is at risk for 
lymphedema? 
 
4 - When will lymphedema 
most likely occur?     
   
5 - What are symptoms  
of lymphedema? 
 
6 - What are lymphedema 
preventive measures? 
 
7 - When should healthcare 
provider be notified? 
 
8 - What can we do prevent 
lymphedema? 
 
9 - When is the patient no 
longer at risk for 
lymphedema? 
 
10 - Lymphedema can be 
cured. 
100% (15) 
 
100% (15) 
 
  
 57% (8) 
 
 
100% (15) 
 
                
         100% (15) 
 
          
100% (15) 
 
          
100% (15) 
                      
 
100% (15) 
 
          
100% (15) 
 
 
 
  100% (15) 
 
100% (17) 
 
 94% (16) 
 
 
 71% (12) 
 
  
 94% (16) 
 
         
         100% (17) 
  
         
100% (17) 
 
         
100% (17) 
         
 
100% (17)    
  
 
     88% (15) 
 
 
 
    65% (6) 
 
All of the nurses that attended the educational program scored 100%.  The nurses 
that did not attend the educational program scored an average of 96%.  There wasn’t a 
very significant difference between the groups for most of the questions. Question 
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number ten, “Lymphedema can be cured”, is an important concept that was answered 
correctly by all those who participated in the education. This indicates that the 
educational seminar was successful.  Levene’s test for equality of variances was found to 
be violated for the present analysis F(1,30) = 2.903, p = .099.  Therefore, in order to test 
the efficacy of the lymphedema education, an independent samples t-test not assuming 
equality of variances was conducted and found to be not statistically significant  
t(22.637) = 1.798, p = 0.085.   
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Chapter V Discussion 
 Overall, there was not a significant difference in the scores between the group that 
received the lymphedema education and the group that did not. The objective was to 
provide an educational program that would be understandable to participants with a wide 
range of education from ancillary staff to registered nurses. Accordingly, a goal was to 
make the test easy enough for all levels of education so that the outcome of participation 
was positive.  
Limitations of the Study 
The small sample size was a major limitation of the study to evaluate the 
effectiveness of an education program on healthcare personnel’s knowledge of the risk of 
and preventive measures for lymphedema in breast cancer patients.  The absence of 
statistical significance between the two groups is likely a result of the relatively small 
total sample size of only 32 persons and may very well not be consistent with the results 
that would be expected with a larger sample size in the same general population. 
Additionally, most, if not all of the test questions were constructed in such a way as to 
lead to the right answer.  
The study setting was limited to one healthcare facility which limits 
generalizability to other healthcare settings. The inclusion of a variety of healthcare 
personnel in the sample increases the generalizability to all healthcare personnel working 
with patients at risk for lymphedema. The convenience sample may have resulted in a 
sample of healthcare personnel who feel intrinsically rewarded by learning and 
improving their healthcare practices.  
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Implications for Nursing 
 Further research should be conducted to investigate the perceived value of 
education of healthcare personnel. As noted, the group (1) that received the pretest 
education did demonstrate a generally higher gross score on the test than the group that 
did not receive the education. Between the two groups, the highest score was found in the 
educated group (97%). The group that did not receive the education received a lower 
score (92%).   
 Further research with a larger sample of healthcare personnel in a variety of 
healthcare settings is recommended to increase generalizability of the research findings. 
A randomized sample would not only increase generalizability but eliminate the self-
selection of individuals who are intrinsically motivated to learn and improve their 
expertise in provision of healthcare.  
Patients with cancer should routinely receive education about their relative risk 
for developing lymphedema. Providing education “could help prevent and reduce 
secondary lymphedema in patients after breast cancer surgery involving dissection of 
axillary lymph nodes, at least for one year after surgery” (Torres, 2010). Patients should 
also be told about risk reduction guidelines such as those contained in the National 
Lymphedema Network (2009).  
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Appendix A 
Demographic Information 
Lymphedema Education Program 
 
I. Age ____________ 
 
II.  Sex 
____Male 
____Female 
 
III. Healthcare Area of Employment 
____Registered Nurse 
____Registration 
____Radiation Oncology Staff 
____Certified Medical Assistant 
 
IV. Years of Experience _____________ 
 
V. Highest Degree Held 
____Associate 
____Bachelors 
____Masters 
____Doctorate 
 
VI.  List any Certifications 
______________________________________________________ 
______________________________________________________ 
______________________________________________________ 
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Appendix B 
Lymphedema Quiz* 
 
1. What is lymphedema? 
a. Cancer treatment 
b. Impaired flow of the lymphatic system 
c. A type of surgery 
d. A rash 
 
2. What is the best way to reduce and manage lymphedema? 
a. Early detection and intervention 
b. Bathing 
c. Never use the arm 
d. Lift weights 
 
3. Who is at risk for lymphedema? 
a. Everyone 
b. Oncology patients 
c. Marathon runners 
d. Patients undergoing breast cancer treatments such as surgery, 
radiation, anyone with a family history of lymphedema 
 
4. When will lymphedema most likely occur? 
a. During adolescence 
b. Before breast cancer treatment 
c. After eating a large meal 
d. Immediately postoperative, during radiation, in a few months, 
years or decades after cancer treatment 
 
5. What are symptoms of lymphedema? 
a. Shrunken extremities 
b. Nausea 
c. Heavy sensation in the limb, decreased flexibility or mobility in 
arm, numbness 
d. Coughing 
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6. What are lymphedema preventive measures? 
a. Surgery 
b. Keep arms in dependent position 
c. Never wear gloves  
d. Exercise, use sunscreen, and do not use arm for blood pressure, 
intravenous or lab sticks, gloves, antibiotic ointment for scratches, 
insect bites. Do not carry heavy objects 
 
7. When should a patient notify a healthcare provider? 
a. Insomnia 
b. For swelling, redness, pain, infection, fever or difficulty moving 
arm 
c. Not until drainage is noted  
d. After swelling continues for two months 
 
8. What can we do to prevent lymphedema? 
a. Do not wear protective clothing 
b. Nothing it is expected 
c. Tell patients not to move their arm after surgery 
d. Assess, educate, provide written materials, refer to physician if 
needed 
 
9. When is the patient no longer at risk for lymphedema? 
a. After surgery 
b. 20 years after axillary node dissection 
c. 5 years after treatment completed 
d. The patient is at risk immediately after surgery, radiation, even 
decades after cancer treatment 
 
10. Lymphedema can be cured. 
a. True 
b. False 
 
*Lymphedema Quiz Answers 1.b,	  2.a,	  3.d,	  4.d,	  5.c,	  6.d,	  7.b,	  8.d,	  9.d,	  10.	  b.	  
